284 related articles for article (PubMed ID: 21538443)
1. Hypoxia-inducible transcription factor 2α promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis.
Qu A; Taylor M; Xue X; Matsubara T; Metzger D; Chambon P; Gonzalez FJ; Shah YM
Hepatology; 2011 Aug; 54(2):472-83. PubMed ID: 21538443
[TBL] [Abstract][Full Text] [Related]
2. Reduction of hepatic fibrosis by overexpression of von Hippel-Lindau protein in experimental models of chronic liver disease.
Wang J; Lu Z; Xu Z; Tian P; Miao H; Pan S; Song R; Sun X; Zhao B; Wang D; Ma Y; Song X; Zhang S; Liu L; Jiang H
Sci Rep; 2017 Jan; 7():41038. PubMed ID: 28112200
[TBL] [Abstract][Full Text] [Related]
3. HIF-1α and HIF-2α are critically involved in hypoxia-induced lipid accumulation in hepatocytes through reducing PGC-1α-mediated fatty acid β-oxidation.
Liu Y; Ma Z; Zhao C; Wang Y; Wu G; Xiao J; McClain CJ; Li X; Feng W
Toxicol Lett; 2014 Apr; 226(2):117-23. PubMed ID: 24503013
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia induces dysregulation of lipid metabolism in HepG2 cells via activation of HIF-2α.
Cao R; Zhao X; Li S; Zhou H; Chen W; Ren L; Zhou X; Zhang H; Shi R
Cell Physiol Biochem; 2014; 34(5):1427-41. PubMed ID: 25323790
[TBL] [Abstract][Full Text] [Related]
5. Loss of von Hippel-Lindau protein (VHL) increases systemic cholesterol levels through targeting hypoxia-inducible factor 2α and regulation of bile acid homeostasis.
Ramakrishnan SK; Taylor M; Qu A; Ahn SH; Suresh MV; Raghavendran K; Gonzalez FJ; Shah YM
Mol Cell Biol; 2014 Apr; 34(7):1208-20. PubMed ID: 24421394
[TBL] [Abstract][Full Text] [Related]
6. Oxygen therapy alleviates hepatic steatosis by inhibiting hypoxia-inducible factor-2α.
Yu L; Wang H; Han X; Liu H; Zhu D; Feng W; Wu J; Bi Y
J Endocrinol; 2020 Jul; 246(1):57-67. PubMed ID: 32369776
[TBL] [Abstract][Full Text] [Related]
7. The HIF-2α/PPARα pathway is essential for liraglutide-alleviated, lipid-induced hepatic steatosis.
Wang H; Wang L; Li Y; Luo S; Ye J; Lu Z; Li X; Lu H
Biomed Pharmacother; 2021 Aug; 140():111778. PubMed ID: 34062416
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor-2 promotes liver fibrosis in non-alcoholic steatohepatitis liver disease via the NF-κB signalling pathway.
Cai H; Bai Z; Ge RL
Biochem Biophys Res Commun; 2021 Feb; 540():67-74. PubMed ID: 33450482
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor 2 regulates hepatic lipid metabolism.
Rankin EB; Rha J; Selak MA; Unger TL; Keith B; Liu Q; Haase VH
Mol Cell Biol; 2009 Aug; 29(16):4527-38. PubMed ID: 19528226
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-2α is essential in activating the COX2/mPGES-1/PGE2 signaling axis in colon cancer.
Xue X; Shah YM
Carcinogenesis; 2013 Jan; 34(1):163-9. PubMed ID: 23042097
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway.
Chen J; Chen J; Fu H; Li Y; Wang L; Luo S; Lu H
Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E710-E722. PubMed ID: 31430204
[TBL] [Abstract][Full Text] [Related]
13. PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma.
Petrella BL; Brinckerhoff CE
Cancer Biol Ther; 2009 Jul; 8(14):1389-401. PubMed ID: 19483472
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein.
Morello E; Sutti S; Foglia B; Novo E; Cannito S; Bocca C; Rajsky M; Bruzzì S; Abate ML; Rosso C; Bozzola C; David E; Bugianesi E; Albano E; Parola M
Hepatology; 2018 Jun; 67(6):2196-2214. PubMed ID: 29266399
[TBL] [Abstract][Full Text] [Related]
15. HIF-2α upregulation mediated by hypoxia promotes NAFLD-HCC progression by activating lipid synthesis via the PI3K-AKT-mTOR pathway.
Chen J; Chen J; Huang J; Li Z; Gong Y; Zou B; Liu X; Ding L; Li P; Zhu Z; Zhang B; Guo H; Cai C; Li J
Aging (Albany NY); 2019 Dec; 11(23):10839-10860. PubMed ID: 31796646
[TBL] [Abstract][Full Text] [Related]
16. Renal tubular HIF-2α expression requires VHL inactivation and causes fibrosis and cysts.
Schietke RE; Hackenbeck T; Tran M; Günther R; Klanke B; Warnecke CL; Knaup KX; Shukla D; Rosenberger C; Koesters R; Bachmann S; Betz P; Schley G; Schödel J; Willam C; Winkler T; Amann K; Eckardt KU; Maxwell P; Wiesener MS
PLoS One; 2012; 7(1):e31034. PubMed ID: 22299048
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-2α activation promotes colorectal cancer progression by dysregulating iron homeostasis.
Xue X; Taylor M; Anderson E; Hao C; Qu A; Greenson JK; Zimmermann EM; Gonzalez FJ; Shah YM
Cancer Res; 2012 May; 72(9):2285-93. PubMed ID: 22419665
[TBL] [Abstract][Full Text] [Related]
18. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
Carroll VA; Ashcroft M
Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo.
Rankin EB; Biju MP; Liu Q; Unger TL; Rha J; Johnson RS; Simon MC; Keith B; Haase VH
J Clin Invest; 2007 Apr; 117(4):1068-77. PubMed ID: 17404621
[TBL] [Abstract][Full Text] [Related]
20. The HIF pathway: implications for patterns of gene expression in cancer.
Wykoff CC; Pugh CW; Harris AL; Maxwell PH; Ratcliffe PJ
Novartis Found Symp; 2001; 240():212-25; discussion 225-31. PubMed ID: 11727931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
